Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats

Regulatory Peptides

Volumn 167, Issue 2-3, 2011, Pages 201-208

  Stengel, Andreas ^a   Coskun, Tamer ^b   Goebel Stengel, Miriam ^a   Craft, Libbey S ^b   Alsina Fernandez, Jorge ^b   Wang, Lixin ^a   Rivier, Jean ^c   Taché, Yvette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Body weight; Brain; Diet induced obesity; Fat mass; Lean body mass; Somatostatin

Indexed keywords

GROWTH HORMONE; ODT8 SST; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY WATER; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FAT MASS; FOOD INTAKE; HORMONE INHIBITION; LEAN BODY WEIGHT; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RESPIRATORY QUOTIENT; TREATMENT DURATION; WEIGHT CHANGE; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; DIET; EATING; INJECTIONS; MALE; OBESITY; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; THINNESS; WEIGHT GAIN;

RATTUS;

EID: 79953172545     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.01.006     Document Type: Article

References (47)

1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179:77-79.
2. Pradayrol L., Jornvall H., Mutt V., Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett 1980, 109:55-58.
3. Brown M., Taché Y. Hypothalamic peptides: central nervous system control of visceral functions. Fed Proc 1981, 40:2565-2569.
4. Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol 1986, 27:63-100.
5. Olias G., Viollet C., Kusserow H., Epelbaum J., Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 2004, 89:1057-1091.
6. Patel Y.C. Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20:157-198.
7. Barnes A.J., Long R.G., Adrian T.E., Vale W., Brown M.R., Rivier J.E., Hanley J., Ghatei M.A., Sarson D.L., Bloom S.R. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin Sci Lond 1981, 61:653-656.
8. Erchegyi J., Grace C.R., Samant M., Cescato R., Piccand V., Riek R., Reubi J.C., Rivier J.E. Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity. J Med Chem 2008, 51:2668-2675.
9. Danguir J. Food intake in rats is increased by intracerebroventricular infusion of the somatostatin analogue SMS 201-995 and is decreased by somatostatin antiserum. Peptides 1988, 9:211-213.
10. Feifel D., Vaccarino F.J. Central somatostatin: a re-examination of its effects on feeding. Brain Res 1990, 535:189-194.
11. Tachibana T., Cline M.A., Sugahara K., Ueda H., Hiramatsu K. Central administration of somatostatin stimulates feeding behavior in chicks. Gen Comp Endocrinol 2009, 161:354-359.
12. Feifel D., Vaccarino F.J., Rivier J., Vale W.W. Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding. Neuroendocrinology 1993, 57:299-305.
13. Rezek M., Havlicek V., Hughes K.R., Friesen H. Central site of action of somatostatin (SRIF): role of hippocampus. Neuropharmacology 1976, 15:499-504.
14. Lin M.T., Chen J.J., Ho L.T. Hypothalamic involvement in the hyperglycemia and satiety actions of somatostatin in rats. Neuroendocrinology 1987, 45:62-67.
15. Vijayan E., McCann S.M. Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone (TRH). Endocrinology 1977, 100:1727-1730.
16. Aponte G., Leung P., Gross D., Yamada T. Effects of somatostatin on food intake in rats. Life Sci 1984, 35:741-746.
17. Stengel A., Coskun T., Goebel M., Wang L., Craft L., Alsina-Fernandez J., Rivier J., Taché Y. Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats. Endocrinology 2010, 151:4224-4235.
18. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P., O'Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E., Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995, 16:86-88.
19. Trevaskis J.L., Lei C., Koda J.E., Weyer C., Parkes D.G., Roth J.D. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity 2010, 18:21-26.
20. Clarke K.J., Whitaker K.W., Reyes T.M. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. J Neuroendocrinol 2009, 21:83-89.
21. Chandler P.C., Wauford P.K., Oswald K.D., Maldonado C.R., Hagan M.M. Change in CCK-8 response after diet-induced obesity and MC3/4-receptor blockade. Peptides 2004, 25:299-306.
22. Gourcerol G., Wang L., Wang Y.H., Million M., Taché Y. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway. Endocrinology 2007, 148:6115-6123.
23. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Mönnikes H., Lambrecht N.W., Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009, 150:4911-4919.
24. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego.
25. Taché Y., Vale W., Rivier J., Brown M. Brain regulation of gastric acid secretion in rats by neurogastrointestinal peptides. Peptides 1981, 2(Suppl 2):51-55.
26. Martinez V., Rivier J., Coy D., Taché Y. Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. J Pharmacol Exp Ther 2000, 293:1099-1105.
27. Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., Moller D.E., Kharitonenkov A. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
28. Ishikawa Y., Shimatsu A., Murakami Y., Imura H. Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide. Pharmacol Biochem Behav 1990, 37:523-526.
29. Kamegai J., Minami S., Sugihara H., Wakabayashi I. Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granular cells of rat cerebellum. Brain Res Mol Brain Res 1993, 18:115-120.
30. Tan H.M., Gundlach A.L., Morris M.J. Exaggerated feeding response to central galanin-like peptide administration in diet-induced obese rats. Neuropeptides 2005, 39:333-336.
31. Hansen M.J., Ball M.J., Morris M.J. Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 2001, 892:130-137.
32. Zhou X., De Schepper J., Vergeylen A., Luis O., Delhase M., Hooghe-Peters E.L. Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus. J Endocrinol Invest 1997, 20:264-269.
33. Hansen M.J., Jovanovska V., Morris M.J. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 2004, 88:909-916.
34. Burgus R., Ling N., Butcher M., Guillemin R. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci USA 1973, 70:684-688.
35. Shimon I., Taylor J.E., Dong J.Z., Bitonte R.A., Kim S., Morgan B., Coy D.H., Culler M.D., Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 1997, 99:789-798.
36. Shimon I., Yan X., Taylor J.E., Weiss M.H., Culler M.D., Melmed S. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest 1997, 100:2386-2392.
37. Rohrer S.P., Birzin E.T., Mosley R.T., Berk S.C., Hutchins S.M., Shen D.M., Xiong Y., Hayes E.C., Parmar R.M., Foor F., Mitra S.W., Degrado S.J., Shu M., Klopp J.M., Cai S.J., Blake A., Chan W.W., Pasternak A., Yang L., Patchett A.A., Smith R.G., Chapman K.T., Schaeffer J.M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998, 282:737-740.
38. Brown M., Taché Y., Rivier J., Pittman Q. Peptides and regulation of body temperature. Neurosecretion and brain peptides 1981, 397-407. Raven Press, New York. J.B. Martin, S. Reichlin, K.L. Bick (Eds.).
39. Johansen P.B., Flyvbjerg A., Wilken M., Malmlof K. Comparison of methods of analysis of body composition in hypophysectomized rats treated with rat growth hormone. Growth Horm IGF Res 2000, 10:342-348.
40. Ng B., Wolf R.F., Weksler B., Brennan M.F., Burt M. Growth hormone administration preserves lean body mass in sarcoma-bearing rats treated with doxorubicin. Cancer Res 1993, 53:5483-5486.
41. Goebel M., Stengel A., Wang L., Coskun T., Rivier J., Taché Y. Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats. Brain Res 2010, 1351:150-164.
42. Meddle S.L., Bull P.M., Leng G., Russell J.A., Ludwig M. Somatostatin actions on rat supraoptic nucleus oxytocin and vasopressin neurones. J Neuroendocrinol 2010, 22:438-445.
43. De Schepper J.A., Smitz J.P., Zhou X.L., Louis O., Velkeniers B.E., Vanhaelst L. Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations. Growth Horm IGF Res 1998, 8:397-401.
44. Kuo L.E., Czarnecka M., Kitlinska J.B., Tilan J.U., Kvetnansky R., Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann NY Acad Sci 2008, 1148:232-237.
45. Arancibia S., Rage F., Grauges P., Gomez F., Tapia-Arancibia L., Armario A. Rapid modifications of somatostatin neuron activity in the periventricular nucleus after acute stress. Exp Brain Res 2000, 134:261-267.
46. Benyassi A., Gavalda A., Armario A., Arancibia S. Role of somatostatin in the acute immobilization stress-induced GH decrease in rat. Life Sci 1993, 52:361-370.
47. Rivier C., Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology 1985, 117:2478-2482.